McOlash L - Search Results

1

A Serum-Induced Transcriptome and Serum Cytokine Signature Obtained at Diagnosis Correlates with the Development of Early Pancreatic Ductal Adenocarcinoma Metastasis.

Tsai S, McOlash L, Jia S, Zhang J, Simpson P, Kaldunski ML, Aldakkak M, Grewal J, Palen K, Dwinell MB, Johnson BD, Mackinnon A, Hessner MJ, Gershan JA. Tsai S, et al. Among authors: mcolash l. Cancer Epidemiol Biomarkers Prev. 2019 Apr;28(4):680-689. doi: 10.1158/1055-9965.EPI-18-0813. Epub 2018 Dec 7. Cancer Epidemiol Biomarkers Prev. 2019. PMID: 30530849 Free PMC article.

2

T Cells Deficient in Diacylglycerol Kinase ζ Are Resistant to PD-1 Inhibition and Help Create Persistent Host Immunity to Leukemia.

Jing W, Gershan JA, Holzhauer S, Weber J, Palen K, McOlash L, Pulakanti K, Wesley E, Rao S, Johnson BD, Riese MJ. Jing W, et al. Among authors: mcolash l. Cancer Res. 2017 Oct 15;77(20):5676-5686. doi: 10.1158/0008-5472.CAN-17-1309. Epub 2017 Sep 15. Cancer Res. 2017. PMID: 28916658

3

Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models.

Tsai S, McOlash L, Palen K, Johnson B, Duris C, Yang Q, Dwinell MB, Hunt B, Evans DB, Gershan J, James MA. Tsai S, et al. Among authors: mcolash l. BMC Cancer. 2018 Mar 27;18(1):335. doi: 10.1186/s12885-018-4238-4. BMC Cancer. 2018. PMID: 29587663 Free PMC article.

4

Combined immune checkpoint protein blockade and low dose whole body irradiation as immunotherapy for myeloma.

Jing W, Gershan JA, Weber J, Tlomak D, McOlash L, Sabatos-Peyton C, Johnson BD. Jing W, et al. Among authors: mcolash l. J Immunother Cancer. 2015 Jan 20;3(1):2. doi: 10.1186/s40425-014-0043-z. eCollection 2015. J Immunother Cancer. 2015. PMID: 25614821 Free PMC article.

5

Adoptive cell therapy using PD-1⁺ myeloma-reactive T cells eliminates established myeloma in mice.

Jing W, Gershan JA, Blitzer GC, Palen K, Weber J, McOlash L, Riese M, Johnson BD. Jing W, et al. Among authors: mcolash l. J Immunother Cancer. 2017 Jun 20;5:51. doi: 10.1186/s40425-017-0256-z. eCollection 2017. J Immunother Cancer. 2017. PMID: 28642819 Free PMC article.

6

STING Activated Tumor-Intrinsic Type I Interferon Signaling Promotes CXCR3 Dependent Antitumor Immunity in Pancreatic Cancer.

Vonderhaar EP, Barnekow NS, McAllister D, McOlash L, Eid MA, Riese MJ, Tarakanova VL, Johnson BD, Dwinell MB. Vonderhaar EP, et al. Among authors: mcolash l. Cell Mol Gastroenterol Hepatol. 2021;12(1):41-58. doi: 10.1016/j.jcmgh.2021.01.018. Epub 2021 Feb 4. Cell Mol Gastroenterol Hepatol. 2021. PMID: 33548597 Free PMC article.

7

Frontline Science: PECAM-1 (CD31) expression in naïve and memory, but not acutely activated, CD8⁺ T cells.

Newman DK, Fu G, McOlash L, Schauder D, Newman PJ, Cui W, Rao S, Johnson BD, Gershan JA, Riese MJ. Newman DK, et al. Among authors: mcolash l. J Leukoc Biol. 2018 Nov;104(5):883-893. doi: 10.1002/JLB.2HI0617-229RRR. Epub 2018 Jul 31. J Leukoc Biol. 2018. PMID: 30063264 Free PMC article.

8

Synchronous effects of targeted mitochondrial complex I inhibitors on tumor and immune cells abrogate melanoma progression.

AbuEid M, McAllister DM, McOlash L, Harwig MC, Cheng G, Drouillard D, Boyle KA, Hardy M, Zielonka J, Johnson BD, Hill RB, Kalyanaraman B, Dwinell MB. AbuEid M, et al. Among authors: mcolash l. iScience. 2021 May 25;24(6):102653. doi: 10.1016/j.isci.2021.102653. eCollection 2021 Jun 25. iScience. 2021. PMID: 34189432 Free PMC article.

9

Immunological evaluation of pediatric cancer patients receiving recombinant interleukin-2 in a phase I trial.

Truitt RL, Piaskowski V, Kirchner P, McOlash L, Camitta BM, Casper JT. Truitt RL, et al. Among authors: mcolash l. J Immunother (1991). 1992 May;11(4):274-85. doi: 10.1097/00002371-199205000-00006. J Immunother (1991). 1992. PMID: 1599913 Clinical Trial.

10

Characterization of CD 200-receptor expression in the murine epidermis.

Rosenblum MD, Woodliff JE, Madsen NA, McOlash LJ, Keller MR, Truitt RL. Rosenblum MD, et al. Among authors: mcolash lj. J Invest Dermatol. 2005 Dec;125(6):1130-8. doi: 10.1111/j.0022-202X.2005.23948.x. J Invest Dermatol. 2005. PMID: 16354182 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page